Sickle Cell Treatment Developed At LA BioMed Enters Phase 3 Clinical Trial

Medical News Today -- An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO have announced .